Clinical trial Recruiting at 1 site Interventional Ages 15 to 18

Digital treatment for adolescents with eating disorders

Official title: Evaluation of a Personalised Digital Treatment for Adolescents With Eating Disorders - An Open Feasibility Trial in Routine Care

Run by Haukeland University Hospital · NCT06306586 · Data updated 2026-11-12

This study is testing a personalized online treatment program for teenagers with eating disorders to see if it helps them improve over 10 weeks.

Quick facts

Study typeInterventional
Ages15 Years to 18 Years
SexAll
Enrollment60 (estimated)
SponsorHaukeland University Hospital
Academic / other
Locations3 sites (Bømlo, Vestland and 2 other locations)
StatusRecruiting
StartedMarch 11, 2024
Main results expectedJanuary 1, 2027
Study endsJanuary 1, 2027
Registry record updatedDecember 22, 2025
Trial IDNCT06306586 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adolescents aged 15 to 18 diagnosed with specific eating disorders who have stable psychiatric treatment and internet access.

Probably not a fit

Patients with anorexia nervosa, bulimia nervosa, or severe psychological disorders may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This feasibility study aims to evaluate a personalized digital treatment for adolescents aged 15 to 18 with eating disorders. Participants will engage in a 10-week program that includes weekly therapist contact and complete self-report questionnaires at various intervals. The study will assess the feasibility of the intervention, identify which adolescents benefit most, and analyze the cost-benefit of the treatment. The research employs a Person-based approach to develop effective behavior change interventions tailored to the needs of the participants.

Why it matters

Potential benefit: If successful, this digital treatment could provide accessible and effective support for adolescents struggling with eating disorders.

How similar studies have gone: Other studies have shown promising results with digital interventions for eating disorders, suggesting potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

A. Diagnosed with F50.1 Atypical anorexia nervosa, F50.3 Atypical bulimia nervosa, F50.8 Other eating disorders, F50.9 Eating disorder, unspecified

B. Age between 15 and 18 years.

C. Stable dose of medication for a co-morbid psychiatric treatment for six weeks and who continue to meet study entry criteria.

D. Internet access.

E. Speaks and write Norwegian.

Exclusion Criteria:

A. Diagnosed with F50.0 Anorexia nervosa or F50.2 Bulimia nervosa

B. Disorders of psychological development (F80-F89).

C. Patients with avoidant restrictive food intake disorders (F50.82)

D. Participants with a co-morbid medical condition or disorder known to influence eating or weight (i.e., pregnancy, cancer), psychotic disorders, acute suicidality, or substance abuse and/or substance dependence and severe depressive episode.

E. Receiving inpatient- or face to face psychological treatment.

Where it's running

  • Haukeland University Hospital
    Bergen, Norway
    Recruiting
  • Bømlo Kommune
    Bømlo, Vestland, Norway
    Withdrawn
  • Helse Fonna
    Haugesund, Norway
    Completed

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.